New Feature: Fill out your Profile to share more about you. Learn more...
Stage IV/Metastatic Breast Cancer, Open to All To Contribute
Archives for June 2022
Discussion List
-
Enhertu Improves Survival in People With HER2-Low MBC
A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer June 6, 2022 Compared with doctors' choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated…
-
Progression
just want to know more about aromasin and afinitor which I will be starting in a couple days
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.